These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 10987052)

  • 21. Exercise and the risk of sudden cardiac death.
    Corrado D; Migliore F; Basso C; Thiene G
    Herz; 2006 Sep; 31(6):553-8. PubMed ID: 17036186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical trials update: sudden cardiac death prevention by implantable device therapy.
    Finch NJ; Leman RB
    Crit Care Nurs Clin North Am; 2005 Mar; 17(1):33-8, x. PubMed ID: 15749399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of sudden death in patients with coronary artery disease.
    Bloom JM
    N Engl J Med; 2000 Apr; 342(17):1291-2. PubMed ID: 10787334
    [No Abstract]   [Full Text] [Related]  

  • 24. [Defibrillators--end of sudden cardiac death?].
    Kozák M
    Vnitr Lek; 2004 Oct; 50 Suppl 1():S63-7. PubMed ID: 15651143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Midlands Trial of Empirical Amiodarone versus Electrophysiology-guided Interventions and Implantable Cardioverter-defibrillators (MAVERIC): a multi-centre prospective randomised clinical trial on the secondary prevention of sudden cardiac death.
    Lau EW; Griffith MJ; Pathmanathan RK; Ng GA; Clune MM; Cooper J; Marshall HJ; Forsey PR; Stafford PJ; Gray RG; Skehan JD; Garratt CJ
    Europace; 2004 Jul; 6(4):257-66. PubMed ID: 15172648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Sudden cardiac death: epidemiology and modern therapy].
    Katz E; Metzger JT; Sierro C; Mischler C; Fishman D; Kappenberg L
    Rev Med Suisse; 2007 Jan; 3(96):302-7. PubMed ID: 17319402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival and appropriate device interventions in recipients of cardioverter defibrillators implanted for the primary versus secondary prevention of sudden cardiac death.
    Stockburger M; Krebs A; Nitardy A; Habedank D; Celebi O; Knaus T; Dietz R
    Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S16-20. PubMed ID: 19250084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sudden death secondary to cardiac arrhythmias: mechanisms and treatment strategies.
    Siddiqui A; Kowey PR
    Curr Opin Cardiol; 2006 Sep; 21(5):517-25. PubMed ID: 16900017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel pathway for sudden cardiac death prevention.
    Herzog E; Aziz EF; Kukin M; Steinberg JS; Mittal S
    Crit Pathw Cardiol; 2009 Mar; 8(1):1-6. PubMed ID: 19258831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MADIT II, the Multi-center Autonomic Defibrillator Implantation Trial II stopped early for mortality reduction, has ICD therapy earned its evidence-based credentials?
    Coats AJ
    Int J Cardiol; 2002 Jan; 82(1):1-5. PubMed ID: 11786150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Long-lasting survival of patients with implantable cardioverter-defibrillators implanted for secondary preventive reasons].
    Kozák M; Sepsi M; Vlasínová J
    Cas Lek Cesk; 2005; 144(5):309-12; discussion 313-4. PubMed ID: 16013516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sudden cardiac death and left ventricular ejection fraction during long-term follow-up after acute myocardial infarction in the primary percutaneous coronary intervention era: results from the HIJAMI-II registry.
    Shiga T; Hagiwara N; Ogawa H; Takagi A; Nagashima M; Yamauchi T; Tsurumi Y; Koyanagi R; Kasanuki H;
    Heart; 2009 Mar; 95(3):216-20. PubMed ID: 18728065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implanted cardioverter defibrillators for the prevention of sudden death.
    Dorian P; Talajic M; Tang A
    Can J Cardiol; 2005 May; 21 Suppl A():31A-36A. PubMed ID: 15953942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of sudden death in patients with coronary artery disease.
    Aggarwal A
    N Engl J Med; 2000 Apr; 342(17):1291; author reply 1291-2. PubMed ID: 10787333
    [No Abstract]   [Full Text] [Related]  

  • 36. Reducing psychosocial stress: a novel mechanism of improving survival from exercise training.
    Milani RV; Lavie CJ
    Am J Med; 2009 Oct; 122(10):931-8. PubMed ID: 19682669
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insertion/deletion polymorphism in alpha2-adrenergic receptor gene is a genetic risk factor for sudden cardiac death.
    Laukkanen JA; Mäkikallio TH; Kauhanen J; Kurl S
    Am Heart J; 2009 Oct; 158(4):615-21. PubMed ID: 19781422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Life expectancy gains and cost-effectiveness of implantable cardioverter/defibrillators for the primary prevention of sudden cardiac death in patients with hypertrophic cardiomyopathy.
    You JJ; Woo A; Ko DT; Cameron DA; Mihailovic A; Krahn M
    Am Heart J; 2007 Nov; 154(5):899-907. PubMed ID: 17967596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of ramipril in reducing sudden deaths and nonfatal cardiac arrests in high-risk individuals without heart failure or left ventricular dysfunction.
    Teo KK; Mitchell LB; Pogue J; Bosch J; Dagenais G; Yusuf S;
    Circulation; 2004 Sep; 110(11):1413-7. PubMed ID: 15353497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization.
    Norhammar A; Malmberg K; Diderholm E; Lagerqvist B; Lindahl B; Rydén L; Wallentin L
    J Am Coll Cardiol; 2004 Feb; 43(4):585-91. PubMed ID: 14975468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.